Sagimet Biosciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Sagimet Biosciences generated cash of -$23,766,000, which is more than the previous year. Cash used in financing activities reached the amount of $86,167,000 last year. Net change in cash is therefore $74,981,000.
Cash Flow
| 2019 | -10.55M | -27K | 18.48M |
|---|---|---|---|
| 2020 | -10.41M | 20K | 68.88M |
| 2021 | -21.71M | 0 | 9.73M |
| 2022 | -24.49M | -32.01M | -73K |
| 2023 | -23.76M | 12.58M | 86.16M |
SGMT Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 158K | 56.73M | 68.70M | 10.21M | 2.30M |
Operating activities | |||||
Net income | -27.87M | -30.49M | -24.44M | -11.37M | -14.26M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 0 | 130K | 0 | 0 | 1K |
Stock-based compensation expense | 4.99M | 1.88M | 1.90M | 775K | 2.98M |
| Deferred income tax benefit | 4.99M | 1.88M | 1.90M | 775K | 2.98M |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 120K | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -23.76M | -24.49M | -21.71M | -10.41M | -10.55M |
Investing activities | |||||
Purchases Of Investments | -19.62M | -41.44M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 12.58M | -32.01M | 0 | 20K | -27K |
Financing activities | |||||
Common Stock Issued | 89.67M | 12K | 0 | 0 | 21.84M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | -3.36M |
Cash used in financing activities | 86.16M | -73K | 9.73M | 68.88M | 18.48M |
Net Change In Cash | 74.98M | -56.57M | -11.97M | 58.49M | 7.90M |
Cash at end of period | 75.13M | 158K | 56.73M | 68.70M | 10.21M |
| Data source |